Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-team-discovers-a-novel-prognostic-biomarker-for-a-doubled-survival-in-head-and-neck-cancer
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-team-discovers-a-novel-prognostic-biomarker-for-a-doubled-survival-in-head-and-neck-cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

A recent study conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) discovered a novel genetic biomarker which can predict the survival of head and neck cancer patients. There are over 0.7 million new head and neck squamous cell carcinoma (HNSCC) cases globally each year. However, currently there is no clinical implementation of any genetic biomarker to predict outcomes for these patients after standard treatment. A study led by Professor Vivian Wai Yan LUI, an expert in genomic medicine and Associate Professor of the School of Biomedical Sciences at CU Medicine, and her research team, has identified that mitogen activated protein kinase (MAPK) pathway mutations found in almost 20% of HNSCC patients can predict favourable clinical outcomes with standard therapy. Their survival also doubled when compared with other patients. The finding has just been published in the journal Life Science Alliance.

 

Survival of HNSCC patients with MAPK pathway mutations is double when compared with patients without these mutations

 

HNSCC include cancers of the oral cavity, pharynx and larynx, with main risk factors like smoking, drinking alcohol, as well as human papillomavirus (HPV) infection. The rising incidence of HNSCC globally is pushing scientists to look for personalised treatment based on the genetic make-up of individual patients. The aggressive nature of HNSCC has often led to aggressive treatments such as chemotherapy and radiation therapy which compromise the quality of life in patients in many cases. In fact, HNSCC survivors have the second highest suicidal rate (64.4/100,000) in the U.S. among all cancer patients (second to pancreatic cancer patients), likely due to psychologic distress and poor quality of life. Thus, an effective way to identify patients who can be treated with less intensive therapies to maintain a better quality of life after treatment has become an emerging focus in the clinical side.

 

The research team has recently discovered that HNSCC patients with MAPK pathway mutations in their tumours have remarkably longer survival than those without (around 95 months vs around 48 months, median overall survival). This feature is only relevant to MAPK pathway mutations. The finding was further validated with another group of HNSCC patients. Data used in the study are from the world’s largest and most comprehensive dataset, The Cancer Genome Atlas (TCGA), and an independent dataset of the Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT).

 

This is the first of its kind in-depth pathway genomic study exploring the potential clinical use of HNSCC patient tumours for clinical outcome prediction. More importantly, the team further examined the potential underlying outcome-favouring reasons through experiments. The research results uncovered the following important findings:

 

  • For the first time, MAPK pathway mutations are discovered to be clinically relevant biomarkers predicting longer survival of HNSCC patients, irrespective of HPV infection and TP53 mutation status. No other signalling pathway mutations can do so thus far.

  • Unlike HPV infection, which can only predict survival of patients with HNSCC at the oropharyngeal site, MAPK pathway mutations can be applied for HNSCC of various head and neck region to predict good patient survival. It may be more universal than HPV.

  • Multiple MAPK pathway mutations can effectively hamper ErbB3 activation signal (an aggressive signal) in the tumour and likely contributed to slower cancer progression.

  • MAPK mutations in HNSCC tumours seem to be able to attract cancer-killing immune T cells. The presence of these anti-tumour immune cells may help control tumour growth by inducing tumour cell apoptosis (potentially after standard treatment).

  • Consistent with our prediction that MAPK pathway mutated HNSCC may have increased anti-tumour immune cells in their tumours, we found that MAPK pathway mutated oral cancer patients could survive 3.3 to 4 times longer than those without upon immunotherapy treatment, suggesting that these MAPK-mutated oral cancer patients may potentially have good responses to immunotherapy.

Professor Vivian Wai Yan LUI, Associate Professor, School of Biomedical Sciences at CU Medicine, remarked, “Our findings that MAPK pathway mutations contribute biologically to better HNSCC patient survival is highly unexpected as MAPK signalling is known to drive cancer growth. It really subverts our understanding of HNSCC. It is also exciting to have identified an HPV infection independent biomarker which can predict a good outcome in the treatment of an HNSCC patient. This finding may lead to future clinical trials for treatment de-intensification on particular patients based on the existence of MAPK pathway mutations in their tumours.”

 

To conclude, the study not only found biomarkers that can predict the therapeutic outcome of patients with HNSCC with standard treatment, but also have a long term impact on its clinical management and bring important implications for how gene mutations can directly shape the tumour’s immune microenvironment in patients.

 

Professor LUI added, “The fact that several major MAPK pathway mutations can directly drive anti-tumour immune cell activities in a HNSCC tumour may change the way we should, perhaps, tailor immunotherapy treatment by giving serious consideration of the genetic make-up of patients’ tumours.” The research team is currently investigating immuno-genomic interactions in head and neck cancer, trying to identify precision immunotherapy strategies to improve immunotherapy treatment.

 

The research study was co-first authored by Professor LUI’s Ph.D. student Mr. Hoi Lam NGAN and post-doctoral fellow Dr. Yuchen LIU. The study was funded by the General Research Fund (GRF # 17114814) awarded by the Research Grant Council of Hong Kong. Study details can refer to: https://www.life-science-alliance.org/content/3/6/e201900545.

More Press Releases

Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
CUHK develops a 3D-printable bioactive material and other technologies to treat large-to-massive tendon injuries

CUHK develops a 3D-printable bioactive material and other technologies to treat large-to-massive tendon injuries

Research
Can animals count?  Neuroscientists at CityUHK and CUHK resolve long-standing debate

Can animals count? Neuroscientists at CityUHK and CUHK resolve long-standing debate

Research
CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

CUHK develops novel molecular classification of cancer-associated fibroblasts across multiple cancers, improving understanding for more targeted treatment

Research
CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

CUHK study finds rising laryngeal cancer rates among women in some locations, despite global decline

Research
A CU Medicine-Baylor College of Medicine collaborative study reveals for the first time that variations in DHX9 underlie human neurodevelopmental disorders

A CU Medicine-Baylor College of Medicine collaborative study reveals for the first time that variations in DHX9 underlie human neurodevelopmental disorders

Research
Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award  Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Professor Anthony Chan honoured with the ESMO Lifetime Achievement Award Global recognition for his leadership and outstanding research in nasopharyngeal cancer

Awards and honors
CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

CUHK Phase 1 Clinical Trial Centre celebrates 10th anniversary Centre has completed 150 early-stage studies of novel drugs for cancer, diabetes and more

Research
CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

CU Medicine’s Assisted Reproductive Technology (ART) Unit preserves the reproductive ability of cancer patients in Hong Kong

Research
CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

CUHK study concludes that plasma EBV DNA screening can detect early asymptomatic nasopharyngeal cancer and reflect the risk of future cancer development

Research
CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

Research
CUHK unravels the world’s most comprehensive genome profile of the American cockroach and reveals novel cockroach allergens for the development of precision immunotherapy

CUHK unravels the world’s most comprehensive genome profile of the American cockroach and reveals novel cockroach allergens for the development of precision immunotherapy

Research
CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

CUHK study sees a rising trend in primary brain cancer incidence in younger males in high-income countries

Research
CUHK discovers a neural architecture that facilitates the formation of associative memory, providing the basis for a deeper understanding of memory and its impairment in brain disorders

CUHK discovers a neural architecture that facilitates the formation of associative memory, providing the basis for a deeper understanding of memory and its impairment in brain disorders

Research
CUHK unlocks the secret of cancer pain  Identifying a new therapeutic key to ending the sorrow

CUHK unlocks the secret of cancer pain Identifying a new therapeutic key to ending the sorrow

Research
CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

CUHK first discovers obese patients with diabetes and fluctuating blood glucose control had a high cancer risk while patients with diabetes treated with a common class of blood pressure lowering drug had a low cancer risk

Research
CUHK’s study sees a rising trend of multiple myeloma incidence,  particularly in older males from high-income countries

CUHK’s study sees a rising trend of multiple myeloma incidence, particularly in older males from high-income countries

Research
CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

CUHK unveils the evolutionary history of medically important mites, laying the genomics groundwork for diagnosis of and intervention in mite allergy

Research
CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

CUHK finds the largest rise in incidence of Hodgkin lymphoma in Asia Rising trend of male incidence means Hong Kong tops the world

Research
CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

CUHK dissects lung carcinoma at single-cell resolution uncovering a new mechanism for tumour formation

Research
CUHK-HKU-UCL study unravels how gene mutation leads to congenital megacolon providing clues for the development of novel therapeutic strategies

CUHK-HKU-UCL study unravels how gene mutation leads to congenital megacolon providing clues for the development of novel therapeutic strategies

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

Research
A Joint Study by CUHK, PolyU and Western Sydney University Discovers how the Nervous System of Human Runners Generates More Energetically Efficient Running Forms

A Joint Study by CUHK, PolyU and Western Sydney University Discovers how the Nervous System of Human Runners Generates More Energetically Efficient Running Forms

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CUHK Study Discovers Brain Circuitry That Generates Behavioural Responses to Stress Provide a Basis for Probing Abnormal Repetitive Behaviour Exhibited in Brain Disorders

CUHK Study Discovers Brain Circuitry That Generates Behavioural Responses to Stress Provide a Basis for Probing Abnormal Repetitive Behaviour Exhibited in Brain Disorders

Research
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Study Discovers Pathway That Links to Cognitive Flexibility Dopamine Dysregulation May Lead to Ability Impairment

CUHK Study Discovers Pathway That Links to Cognitive Flexibility Dopamine Dysregulation May Lead to Ability Impairment

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Study Discovers an Essential Enzyme to Maintain Body Iron Homeostasis Deficiency Could Cause Excessive Iron Retention and Damage Major Organs

CUHK Study Discovers an Essential Enzyme to Maintain Body Iron Homeostasis Deficiency Could Cause Excessive Iron Retention and Damage Major Organs

Research
CUHK School of Biomedical Sciences Strives to Become the World-leading Biomedical Hub

CUHK School of Biomedical Sciences Strives to Become the World-leading Biomedical Hub

Milestone
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

CUHK’s Gerald Choa Neuroscience Centre Unveils Mystery of How Brain Learns Motor Skills

Research
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

CUHK-led Study Reveals Novel Mechanism for the Development of Atherosclerosis Setting New Treatment Directions to Cardiovascular Diseases

Research
CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

CUHK Launches World’s First Study on Ovum Ageing and Female Infertility by Using Single-Cell Genomics Technology

Research
CUHK/International Study Implicates a Gene in Alzheimer’s disease

CUHK/International Study Implicates a Gene in Alzheimer’s disease

Research
CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

CUHK Unveils Genome of Dermatophagoides farinae Casting New Light on Diagnosis and Interventions of Inhalant Allergies

Research
The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

The 7th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care in the Community’

Symposium
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research
CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

CUHK and HKU Host the 5th Annual Palliative Care Symposium for Health Care Workers in Chinese Population

Symposium
CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

CUHK Pioneers Innovative Computer Assisted Tumor Surgery for Bone Cancer Patients

Surgical advancement
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

CUHK and US Experts Collaborate to Provide Clinical Genetic Training to Set up The Territory's First One-Stop Outpatient Genetic Clinic

International collaboration
CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

CUHK Lo Kwee-Seong Integrated Biomedical Sciences Building Opened

Milestone
The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

The Chinese University of Hong Kong Nethersole School of Nursing hosts the Fifth Pan-Pacific Nursing Conference and Seventh Nursing Symposium on Cancer Care

Symposium
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.